Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by (999)

Items 301–400 of 999

1. Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
   Remco Franssen, Raaj R. Sankatsing, Elly A. M. Hassink, Barbara A. Hutten, Mariëtte T. Ackermans, Kees Brinkman, René Oesterholt, Alejandro Arenas‐Pinto, Stephen P. Storfer, John J.P. Kastelein et al. · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
2. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: A systematic review and meta-analysis
   Chidozie U Nduka, Ahmed Mohammed Sarki, Olalekan Abdulrahman Uthman, Saverio Stranges · 2015 · International Journal of Cardiology
3. Ezetimibe Alone Reduces Low‐Density Lipoprotein Cholesterol in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy
   David Alain Wohl, David D. Waters, Ross J. Simpson, Susan Richard, Amanda Schnell, Sonia Napravnik, Jessica Keys, Joseph J. Eron, Priscilla Y. Hsue · 2008 · Clinical Infectious Diseases
4. Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets
   Morris Madzime, Theresa M. Rossouw, Annette J. Theron, Ronald Anderson, Helen C. Steel · 2021 · Frontiers in Immunology
5. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study
   Giuseppe Vittorio De Socio, Giustino Parruti, Tiziana Quirino, Elena Delfina Ricci, Giuseppe Schillaci, Beatrice Adriani, Patrizia Marconi, Marzia Franzetti, Canio Vito Martinelli, Francesca Vichi et al. · 2008 · Journal of Infection
6. Yearly Zoledronic Acid in Postmenopausal Osteoporosis
   R. N. J. de Nijs, Antonius A. A. Westgeest · 2007 · New England Journal of Medicine
7. Differences between HIV ‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies
   M Calvo‐Sánchez, Rafel Perelló, Ignacio Pérez, M. Gracia Mateo, Mireia Junyent, Montserrat Laguno, JL Blanco, Maria Martínez‐Rebollar, M Sánchez, Josep Mallolas et al. · 2012 · HIV Medicine
8. Decline in locomotor functions over time in HIV-infected patients
   Laura E. Richert, Mathilde Brault, P. Mercié, Frédéric‐Antoine Dauchy, Mathias Bruyand, Carine Greib, François Dabis, Fabrice Bonnet, Geneviève Chêne, Patrick Dehail · 2014 · AIDS
9. HIV infection and aging.
   José Ramón Blanco, Ana María Caro-Murillo, Santiago Pérez Cachafeiro, Félix Gutiérrez, José Antonio Iribarren, Juan González‐García, Sara Ferrando‐Martínez, Gema Navarro, Santiago Moreno · 2010 · PubMed
10. The Relationship Between HIV Infection and Cardiovascular Disease
    Birgitt Dau, Mark Holodniy · 2008 · Current Cardiology Reviews
11. Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back
    Ana Milinkovic, Florian Berger, Alejandro Arenas‐Pinto, Stefan Mauss · 2019 · AIDS
12. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Estebán Martínez, María Larrousse, José M. Gatell · 2008 · Current Opinion in Infectious Diseases
13. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
    C. William Wester, John Robert Koethe, Bryan E. Shepherd, Samuel E. Stinnette, Peter F. Rebeiro, Aaron M. Kipp, Hwanhee Hong, Hermann Bussmann, Tendani Gaolathe, Catherine C. McGowan et al. · 2011 · AIDS
14. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
    For the investigators of the Canadian HIV and Aging Cohort Study, Madéleine Durand, Carl Chartrand‐Lefebvre, Jean-Guy Baril, Sylvie Trottier, Benoît Trottier, Marianne Harris, Sharon Lynn Walmsley, Brian Conway, Alexander Wong et al. · 2017 · BMC Infectious Diseases
15. The struggle of a good friend getting old: cellular senescence in viral responses and therapy
    Kohli, Jaskaren, Veenstra, Iris, Demaria, Marco · 2021 · The EMBO Reports
16. Stroke in HIV infection and AIDS
    Michael Dobbs, Joseph R. Berger · 2009 · Expert Review of Cardiovascular Therapy
17. Risk factors for incident diabetes mellitus among HIV‐infected patients receiving combination antiretroviral therapy in Taiwan: a case–control study
    Y‐C Lo, M‐Y Chen, W‐H Sheng, S‐M Hsieh, H‐Y Sun, W.-C. Liu, P‐Y Wu, Chien‐Hui Wu, C‐C Hung, S‐C Chang · 2009 · HIV Medicine
18. Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
    Kathleen M. S. E. Reyskens, Tarryn-Lee Fisher, Jonathan Cummings Schisler, Wendi G. O'Connor, Arlin B. Rogers, Monte S. Willis, Cynthia Planesse, Florence Boyer, Philippe Rondeau, Emmanuel Bourdon et al. · 2013 · PLoS ONE
19. Evidence-based review of statin use in patients with HIV on antiretroviral therapy
    Chastain, Daniel B., Stover, Kayla R., Riche, Daniel M. · 2017 · Journal of Clinical & Translational Endocrinology
20. Increased non‐ AIDS mortality among persons with AIDS ‐defining events after antiretroviral therapy initiation
    April Christine Pettit, Mark J Giganti, Suzanne Marie Ingle, Margaret May, Bryan E. Shepherd, Michael John Gill, Gerd Fätkenheuer, Sophie Abgrall, Michael S. Saag, Julia del Amo et al. · 2018 · Journal of the International AIDS Society
21. Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D:A:D Cohort Analysis
    Amit C. Achhra, Caroline Anne Sabin, Lene Ryom, Camilla Ingrid Hatleberg, Monforte Antonella d'Aminio, Stéphane De Wit, Andrew N. Phillips, Christian Pradier, Rainer Weber, Peter Reiss et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
22. Focus on the heart: alcohol consumption, HIV infection, and cardiovascular disease.
    Matthew S. Freiberg, Kevin L. Kraemer · 2010 · Europe PMC (PubMed Central)
23. Accelerated Aging in HIV Patients
    Keren Meir‐Shafrir, Shimon Pollack · 2012 · Rambam Maimonides Medical Journal
24. Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals
    Stefania Piconi, S. Parisotto, Giuliano Rizzardini, Simone Passerini, Paola Meraviglia, Monica Schiavini, Fosca P. Niero, Mara Biasin, Paolo Bonfanti, Elena Delfina Ricci et al. · 2012 · AIDS
25. Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients
    James H. Stein, Colleen M. Hadigan, Todd Tarquin Brown, ELLEN GOULD CHADWICK, Judith Feinberg, Nina Friis‐Møller, Anuradha Ganesan, Marshall Jay Glesby, David Hardy, Robert C. Kaplan et al. · 2008 · Circulation
26. Lipid Metabolism in Treated HIV Infection
    Michael P. Dubé, Joseph J. Cadden · 2011 · Best Practice & Research Clinical Endocrinology & Metabolism
27. Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
    BRUCE H. THIERS · 2008 · Yearbook of Dermatology and Dermatologic Surgery
28. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
    C. Noel Bairey Merz, Mark J. Alberts, Gary John Balady, Christie Mitchell Ballantyne, Kathy A. Berra, Henry R. Black, Roger Scott Blumenthal, Michael H. Davidson, Sara B. Fazio, Keith C. Ferdinand et al. · 2009 · Journal of the American College of Cardiology
29. Haemophilia and ageing
    Susan Shapiro, Mike Makris · 2018 · British Journal of Haematology
30. Evidence-Based Practice: Toward Optimizing Clinical Outcomes
    Francesco Chiappelli · 2010 · Springer eBooks
31. Changes in Causes of Death Among Persons with AIDS: San Francisco, California, 1996–2011
    Sandra K. Schwarcz, Annie Vu, Ling Chin Hsu, Nancy A. Hessol · 2014 · AIDS Patient Care and STDs
32. Aggregate Risk of Cardiovascular Disease Among Adolescents Perinatally Infected With the Human Immunodeficiency Virus
    Kunjal Patel, Jiajia Wang, Denise L. Jacobson, Steven E. Lipshultz, David C. Landy, Mitchell E. Geffner, Linda Anne DiMeglio, George R. Seage, Paige L. Williams, Russell B. Van Dyke et al. · 2013 · Circulation
33. Increased risk of cardiovascular disease ( CVD ) with age in HIV ‐positive men: a comparison of the D : A : D CVD risk equation and general population CVD risk equations
    Kathy Petoumenos, Peter Reiss, Lene Ryom, Martin Rickenbach, Caroline Anne Sabin, Wafaa El‐Sadr, Antonella d’Arminio Monforte, Andrew N. Phillips, Stéphane De Wit, Ole Kirk et al. · 2014 · HIV Medicine
34. Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    Anne Maagaard, Dag Kvale · 2009 · Journal of Antimicrobial Chemotherapy
35. The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy
    John Robert Koethe, Heather N. Grome, Cathy A. Jenkins, Spyros A. Kalams, Timothy R. Sterling · 2015 · AIDS
36. The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
    Jason V. Baker, W. Keith Henry, James D. Neaton · 2009 · Current Opinion in HIV and AIDS
37. Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials
    Alan Raymond Lifson, Waldo Horacio Belloso, Cate Carey, Richard T. Davey, Daniel A. Duprez, Wafaa M. El-Sadr, José M. Gatell, Daniela Gey, Jennifer Hoy, Eric A. Krum et al. · 2008 · HIV Clinical Trials
38. Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
    Muralikrishna Gopal, Archana Bhaskaran, Wissam I. Khalife, Alejandro Barbagelata · 2009 · Current Cardiology Reviews
39. Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya
    Tecla Mtui Temu, Nicholas Kirui, Celestine N. Wanjalla, Alfred M. Ndungu, Jemima Hoine Kamano, Thomas S. Inui, Gerald S. Bloomfield · 2015 · BMC Infectious Diseases
40. Tobacco Use and Cessation in HIV-Infected Individuals
    Kristine K. Browning, Mary Ellen Wewers, Amy K. Ferketich, Philip Diaz · 2013 · Clinics in Chest Medicine
41. Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy
    William Muronya, Esther Sanga, George C. Talama, Johnstone J. Kumwenda, Joep J. van Oosterhout · 2011 · Transactions of the Royal Society of Tropical Medicine and Hygiene
42. Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS
    Ovidiu A. Galescu, Amrit Bhangoo, Svetlana Ten · 2013 · Reviews in Endocrine and Metabolic Disorders
43. Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection
    Leonardo Calza, Giovanni Masetti, Benedetta Piergentili, Filippo Trapani, Alessandra Cascavilla, Roberto Manfredi, Vincenzo Colangeli, Pierluigi Viale · 2011 · International Journal of STD & AIDS
44. Switching to Tenofovir/Emtricitabine from Abacavir/ Lamivudine in HIV-Infected Adults with Raised Cholesterol: Effect on Lipid Profiles
    Georg M. N. Behrens, Renato Maserati, Armin Rieger, Peré Domingo, Florian Abel, Hui Wang, Gill Pearce · 2012 · Antiviral Therapy
45. Recent Developments regarding Human Immunodeficiency Virus Infection and Stroke
    Souvik Sen, Alejandro A. Rabinstein, Mitchell S.V. Elkind, William J. Powers · 2012 · Cerebrovascular Diseases
46. Risk factors related to hypertension among patients in a cohort living with HIV/AIDS
    Evanízio Roque de Arruda, Heloísa Ramos Lacerda, Líbia Cristina Rocha Vilela Moura, Maria de Fátima Pessoa Militão de Albuquerque, Demócrito de Barros Miranda-Filho, George Tadeu Nunes Diniz, Valéria Maria Gonçalves de Albuquerque, Josefina Cláudia Zirpoli Amaral, Ricardo Arraes de Alencar Ximenes, Verônica Soares Monteiro · 2010 · The Brazilian Journal of Infectious Diseases
47. HIV Infection Is Not Associated with Carotid Intima-Media Thickness in Brazil: A Cross-Sectional Analysis from the INI/ELSA-Brasil Study
    Antônio Guilherme Pacheco, Beatriz Gilda Jegerhorn Grinsztejn, Maria de Jesus Mendes da Fonseca, Rosane Härter Griep, Paulo A. Lotufo, Isabela M Benseñor, José Geraldo Mill, Rodrigo de Carvalho Moreira, Ronaldo Ismerio Moreira, Ruth Khalili Friedman et al. · 2016 · PLoS ONE
48. Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitors
    Raaj R. Sankatsing, Ferdinand W.N.M. Wit, Martin Vogel, Eric de Groot, Kees Brinkman, Juergen Kurt Rockstroh, John J.P. Kastelein, Erik S.G. Stroes, Peter Reiss · 2008 · Atherosclerosis
49. Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV
    José Gutierrez, James E. Goldman, Andrew J. Dwork, Mitchell S.V. Elkind, Randolph S. Marshall, Susan Morgello · 2015 · Neurology
50. Managing dyslipidemia in HIV/AIDS patients: challenges and solutions
    Mohamed Ahmed, Nazik Elmalaika Husain · 2014 · HIV/AIDS - Research and Palliative Care
51. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy
    Robert L. Murphy, Baiba Berzins, Carlos Zala, Carl J. Fichtenbaum, Michael P. Dubé, Giovanni Guaraldi, Francesca J. Torriani, Elizabeth M. Belsey, Carol Mitchell, James H. Stein · 2010 · AIDS
52. The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy
    Eefje Jong, Susan J. Louw, Joost C.M. Meijers, Martijn D. de Kruif, Hugo Ten Cate, Harry Roger Buller, Jan Willem Mulder, Eric C. M. Van Gorp · 2009 · AIDS Patient Care and STDs
53. Body mass index in individuals with HIV infection and factors associated with thinness and overweight/obesity
    Carolline Araujo, Maria de Fátima P. Militão de Albuquerque, Ricardo Arraes de Alencar Ximenes, Heloísa Ramos Lacerda, Francisco Alfredo Farias Bandeira, Thais Gelenske, Érico Higino de Carvalho, Adriana Paula da Silva, Demócrito de Barros Miranda-Filho · 2011 · Cadernos de Saúde Pública
54. Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials
    Dianne Carey, Janaki Amin, Mark Alastair Boyd, Kathy Petoumenos, Sean Emery · 2010 · Journal of Antimicrobial Chemotherapy
55. Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years—The Australian Positive & Peers Longevity Evaluation Study (APPLES)
    Kathy Petoumenos, Robin Huang, Jennifer Hoy, Mark Theo Bloch, David James Templeton, David A Baker, Michelle Giles, Matthew G. Law, David A. Cooper · 2017 · PLoS ONE
56. Cardiotoxic drugs: clinical monitoring and decision making
    Audrey H. Wu · 2008 · Heart
57. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
    Pedro Enrique Cahn, O. H. M. Leite, A. Rosales, Robinson L. Cabello, Carlos Álvarez, Carlos Seas, César Cárcamo, Nancy Cure-Bolt, Gilber L'Italien, P Mantilla et al. · 2010 · The Brazilian Journal of Infectious Diseases
58. Cardiovascular Risks of Antiretroviral Therapy
    James H. Stein · 2007 · New England Journal of Medicine
59. Arterial Disease in Patients With Human Immunodeficiency Virus Infection
    James H. Stein, Judith S. Currier, Priscilla Y. Hsue · 2014 · JACC. Cardiovascular imaging
60. Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
    Alan MacInnes, Adriano Lazzarin, Giovanni Di Perri, Juan Gerardo Sierra-Madero, Judith A. Aberg, Jayvant Heera, Natasa Rajicic, James Goodrich, Heather S. Mayer, Hernán Valdez · 2011 · HIV Clinical Trials
61. Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function
    Samir Kumar Gupta, Deming Mi, Sharon M. Moe, Michael P. Dubé, Ziyue Liu · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
62. Lessons Learned From the Design and Implementation of Myocardial Infarction Adjudication Tailored for HIV Clinical Cohorts
    Heidi M. Crane, Susan R. Heckbert, Daniel R. Drozd, Matthew Jay Budoff, Joseph A. Delaney, Carla V. Rodriguez, Pathmaja Paramsothy, William B. Lober, Greer Burkholder, James H. Willig et al. · 2014 · American Journal of Epidemiology
63. Platelet Transcriptome Profiling in HIV and ATP-Binding Cassette Subfamily C Member 4 (ABCC4) as a Mediator of Platelet Activity
    Emanuela Marcantoni, Nicole Allen, Matthew R. Cambria, Rebecca Byler Dann, Michael Cammer, Tenzin W. Lhakhang, Meagan P. O’Brien, Benjamin B. Kim, Tilla S. Worgall, Adriana Heguy et al. · 2018 · JACC Basic to Translational Science
64. Pharmacogenetics of adverse effects due to antiretroviral drugs.
    Francesc Vidal, Félix Gutiérrez, María del Mar Gutiérrez, Montserrat Olona, Victoria Sánchez, Gracia María Mateo, Joaquim Peraire, Consuelo Viladés, Sergio Veloso, Miguel López-Dupla et al. · 2010 · PubMed
65. Atherosclerosis risk in HIV-infected patients: The influence of hepatitis C virus co-infection
    Philippe Sosner, Marc Wangermez, Carine Chagneau-Derrode, Gwenael Le Moal, Christine Silvain · 2012 · Atherosclerosis
66. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection
    James H. Stein, Todd Tarquin Brown, Heather Jane Ribaudo, Yun Chen, Mingzhu Yan, Elizabeth Lauer-Brodell, Grace A. McComsey, Michael P. Dubé, Robert L. Murphy, Howard Neil Hodis et al. · 2012 · AIDS
67. Cardiovascular toxicity of abacavir
    Ángeles Álvarez, Samuel Orden, Isabel Andújar, Víctor Collado‐Díaz, Sara Núñez-Delgado, Marı́a José Galindo, Vicente Estrada, Nadezda Apostolova, Juan Vicente Esplugues · 2017 · AIDS
68. The Association Between the Receipt of Lipid Lowering Therapy and HIV Status Among Veterans Who Met NCEP/ATP III Criteria for the Receipt of Lipid Lowering Medication
    Matthew S. Freiberg, David A. Leaf, Joseph Lucien Goulet, Matthew Bidwell Goetz, Krisann K. Oursler, Cynthia L. Gibert, Maria C. Rodriguez‐Barradas, Adeel Ajwad Butt, Amy C. Justice · 2009 · Journal of General Internal Medicine
69. Screening for HIV: systematic review to update the 2005 U.S. Preventive Services Task Force recommendation.
    Chou, Roger, Selph, Shelley, Dana, Tracy, Bougatsos, Christina, Zakher, Bernadette, Blazina, Ian, Korthuis, P. Todd · 2012 · Annals of Internal Medicine
70. Dyslipidemia in Human Immunodeficiency Virus Disease
    Dinesh Kumar Kalra, Mounica Vorla, Erin D. Michos, Anandita Agarwala, Salim S. Virani, Paul Barton Duell, Frederick Johan Raal · 2023 · Journal of the American College of Cardiology
71. Peripheral Arterial Disease in HIV Patients Older than 50 Years of Age
    Rosario Palacios, Inmaculada Alonso, Ana Hidalgo, Isabel Aguilar, Miguel A. Sánchez, Pedro Valdivielso, Pedro González‐Santos, Jesús Santos · 2008 · AIDS Research and Human Retroviruses
72. Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood
    David Dimock, Vijaya M. Thomas, Anna M. Cushing, Julia Purdy, Carol J. Worrell, Jeffrey B. Kopp, Rohan Hazra, Colleen M. Hadigan · 2010 · Metabolism
73. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1
    Babafemi Taiwo, Charles B. Hicks, Joe Eron · 2010 · Journal of Antimicrobial Chemotherapy
74. HIV and Africa's elderly
    Eran Bendavid, Nathan Paul Ford, Edward J. Mills · 2012 · AIDS
75. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults
    Steven E. Lipshultz, Catherine M. Mas, Jacqueline M. Henkel, Vivian I. Franco, Stacy D. Fisher, Tracie L. Miller · 2012 · Expert Review of Anti-infective Therapy
76. Prognostic Indicators for Recurrent Thrombotic Events in HIV-infected Patients with Acute Coronary Syndromes: Use of Registry Data From 12 sites in Europe, South Africa and the United States
    Fabrizio D’Ascenzo, Enrico Cerrato, Darryn L. Appleton, Claudio Moretti, Andrea Calcagno, Nayef Antar Abouzaki, George Wayne Vetrovec, Thibault Lhermusier, Didier Carrié, Barbara Das Neves et al. · 2014 · Thrombosis Research
77. Long-Term Cocaine Use and Antiretroviral Therapy Are Associated with Silent Coronary Artery Disease in African Americans with HIV Infection Who Have No Cardiovascular Symptoms
    Shenghan Lai, Elliot K. Fishman, Hong C. Lai, Richard D. Moore, Joseph Cofrancesco, Harpreet K. Pannu, W. Tong, J. Du, J. Bartlett · 2008 · Clinical Infectious Diseases
78. PET/MR imaging of inflammation in atherosclerosis
    Max L. Senders, Claudia Calcagno, Ahmed A Tawakol, Matthias Nahrendorf, Willem J. M. Mulder, Zahi Adel Fayad · 2022 · Nature Biomedical Engineering
79. Analysis of serious non‐AIDS events among HIV‐infected adults at Latin American sites
    Waldo Horacio Belloso, Liliana Orellana, Beatriz Gilda Jegerhorn Grinsztejn, J. G. Sierra Madero, Alberto La Rosa, VG Veloso, Jorge Sánchez, Ronaldo Ismerio Moreira, Brenda Crabtree‐Ramírez, Oscar García Messina et al. · 2010 · HIV Medicine
80. Abacavir and cardiovascular risk
    Georg M. N. Behrens, Peter Reiss · 2009 · Current Opinion in Infectious Diseases
81. Management of lipid disorders in patients living with HIV
    Merle L. Myerson, Carlos Malvestutto, Judith A. Aberg · 2015 · The Journal of Clinical Pharmacology
82. Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study
    Jeffrey Olarinde Ogunmola, Olatunji Oladosu, Michael Adeyemi Olamoyegun · 2014 · Vascular Health and Risk Management
83. Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials
    Alan Raymond Lifson, Waldo Horacio Belloso, Richard T. Davey, Daniel A. Duprez, José M. Gatell, Jennifer Hoy, Eric A. Krum, Ray Nelson, Court Pedersen, George V. Pérez et al. · 2010 · HIV Clinical Trials
84. Cardiometabolic risk factors among HIV patients on antiretroviral therapy
    James N Kiage, Douglas Corbett Heimburger, Christopher K. Nyirenda, Melissa Wellons, Shashwatee Bagchi, Benjamin H Chi, John Robert Koethe, Donna K. Arnett, Edmond Kato Kabagambe · 2013 · Lipids in Health and Disease
85. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case–control study
    Ali Judd, Katherine Boyd, Wolfgang Stöhr, David T. Dunn, KARINA M. BUTLER, Hermione Lyall, Mike Sharland, Delane V. Shingadia, Andrew I Riordan, Diana M. Gibb · 2010 · AIDS
86. Epidemiology of ischemic heart disease in HIV
    Virginia A. Triant, Steven Kyle Grinspoon · 2017 · Current Opinion in HIV and AIDS
87. Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV ‐positive persons: the Data Collection on Adverse Events of Anti‐ HIV Drugs (D:A:D) study
    Camilla Ingrid Hatleberg, Lene Ryom, Antonella d’Arminio Monforte, Éric Fontas, Peter Reiss, Ole Kirk, Wafaa El‐Sadr, Andrew N. Phillips, Stéphane De Wit, François Dabis et al. · 2018 · HIV Medicine
88. Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy
    Belinda Cruse, Lucette A. Cysique, Romesh Markus, Bruce James Brew · 2012 · Journal of NeuroVirology
89. Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial
    Andreas J. Flammer, N T T Vo, Bruno Ledergerber, Matthias Hermann, Andrea Gämperli, Angela Csaki Huttner, J. Evison, Iris Baumgärtner, Matthias L. Cavassini, Daniel Hayoz et al. · 2008 · Heart
90. Microbial Translocation and Cardiometabolic Risk Factors in HIV Infection
    Marius Trøseid, Ingjerd Wangensteen Manner, Karin Kaereby Pedersen, Judith M. Haissman, Dag Kvale, Susanne Dam Nielsen · 2014 · AIDS Research and Human Retroviruses
91. Rapidly ageing HIV epidemic among men who have sex with men in Australia
    John Michael Murray, Ann M. McDonald, Matthew G. Law · 2009 · Sexual Health
92. Long term adverse effects related to nucleoside reverse transcriptase inhibitors: Clinical impact of mitochondrial toxicity
    Anne Maagaard, Dag Kvale · 2009 · Scandinavian Journal of Infectious Diseases
93. Abacavir and Cardiovascular Risk: Reviewing the Evidence
    Dominique G. Costagliola, Sylvie Lang, Murielle Mary‐Krause, Franck Boccara · 2010 · Current HIV/AIDS Reports
94. Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls
    Leonardo Calza, Daria Pocaterra, Michele Pavoni, Vincenzo Colangeli, Roberto Manfredi, Gabriella Verucchi, Francesco Chiodo, Marco Cantù, Milena Pariali · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
95. Cardiac Diastolic Dysfunction Is Prevalent in HIV-Infected Patients
    Gautam S. Nayak, Michael A. Ferguson, David R. Tribble, Chad K. Porter, Robert Rapena, Marc Marchicelli, Catherine F. Decker · 2009 · AIDS Patient Care and STDs
96. Management of cardiovascular complications in systemic lupus erythematosus
    Carly Skamra, Rosalind Ramsey‐Goldman · 2010 · International Journal of Clinical Rheumatology
97. Biomarkers of Vascular Dysfunction in Children Infected With Human Immunodeficiency Virus-1
    Tracie L. Miller, Gabriel A. Somarriba, Endel John Orav, Armando J. Mendez, Daniela Almeida Neri, Natasha Schaefer, Lourdes Forster, Ronald B Goldberg, Gwendolyn B. Scott, Steven E. Lipshultz · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
98. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries
    Sylvie Lang, Franck Boccara, Murielle Mary‐Krause, Ariel A. Cohen · 2015 · Archives of cardiovascular diseases
99. Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
    Nazisa Hejazi, MSL Huang, Khor Geok Lin, Lee Christopher Kwok Choong · 2013 · Global Journal of Health Science
100. Elevated Numbers of CD163 + Macrophages in Hearts of Simian Immunodeficiency Virus-Infected Monkeys Correlate with Cardiac Pathology and Fibrosis
     Joshua Walker, Megan L. Sulciner, Katherine D. Nowicki, Andrew David Miller, Tricia H. Burdo, Kenneth C. Williams · 2014 · AIDS Research and Human Retroviruses